Table 2 Pre-and postoperative records per patient
Indication | Age/ gender | Lens Status | Time to HSO (months) | IOP after Oxane | Number IOP Meds | IOP Final | Number IOP Meds | Time Follow up (months) | Baseline VA | Final VA | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
RRD | 60/ M | Phakic | 7 | 11 | 0 | 17 | 0 | 42 | 20/200 | 20/60 | ERM |
RRD | 75/ F | Pseudo | 6 | 16 | 1 | 16 | 0 | 10 | CF 1 M | 20/160 | |
RRD | 55/ M | Phakic | 15 | 16 | 2 | 18 | 2 | 18 | CF 1 M | CF 2 M | |
RRD | 64/ F | Phakic | 2 | 14 | 0 | 16 | 0 | 9 | HM | ND | |
RRD | 55/ M | Pseudo | 10 | 13 | 0 | 13 | 0 | 4 | HM | HM | |
RRD | 50/ M | Phakic | 6 | 13 | 0 | 13 | 0 | 7 | HM | 20/100 | |
RRD | 38/ M | Phakic | 13 | 10 | 0 | 16 | 0 | 61 | 20/150 | 20/160 | |
RRD | 24/ F | Phakic | 5 | 14 | 2 | 23 | 1 | 8 | HM | 20/400 | |
RRD | 58/ F | Phakic | 2 | 10 | 4 | 21 | 2 | 3 | HM | 20/200 | |
RRD | 67/ M | Phakic | 9 | 20 | 2 | 24 | 2 | 36 | CF 0.1 M | CF 1 M | SO emulsification, SLT after DEX implants, after SOR |
RRD | 57/ M | Phakic | 3 | 20 | 3 | 14 | 0 | 12 | ND | 20/50 | RRD secondary to uveitis |
RRD | 57/ M | Aphakic | 3 | 14 | 2 | 0 | 0 | 5 | ND | LP | Aphakic, globe atrophy |
RRD | 65/ M | Pseudo | NA | 9 | 1 | 13 | 0 | 25 | 20/60 | 20/80 | Permanent Oxane |
RRD | 50/ F | Pseudo | NA | 12 | 0 | 10 | 0 | 39 | CF 1 M | HM | Previous IONN, severe PCO, Permanent SO |
RRD | 53/ M | Phakic | NA | 12 | 0 | 12 | 0 | 2 | HM | 20/400 | Lost follow up |
RRD | 45/ M | Aphakic | NA | 16 | 3 | 14 | 2 | 38 | HM | LP | Bullous keratopathy, Permanent Oxane |
RRD | 52/ F | Phakic | NA | 14 | 0 | 12 | 0 | 24 | HM | HM | Permanent Oxane |
RRD | 77/ M | Pseudo | NA | 12 | 2 | 13 | 0 | 5 | ND | 20/120 | |
RRD | 88/ F | Phakic | 1 | 14 | 4 | 13 | 2 | 52 | HM | HM | AMD macular scar, Oxane removed, Permanent SO |
RRD | 76/ M | Pseudo | 4 | ND | ND | 14 | 0 | 4 | ND | CF 2 M | Previous corneal graft and advanced AMD |
RRD | 40/ F | Phakic | 11 | 12 | 2 | 16 | 0 | 60 | 20/30 | 20/160 | SO emulsification, Ciclophotocoagulation |
RRD | 68/ F | Pseudo | 6 | 13 | 3 | 12 | 2 | 10 | 20/100 | 20/30 | |
RRD | 58/ M | Phakic | 13 | 16 | 3 | 17 | 3 | 25 | 20/125 | 20/100 | |
RRD | 70/ M | Pseudo | 18 | 18 | 0 | 11 | 0 | 39 | 20/100 | CF 1 M | Oxane removed, Permanent SO |
RRD | 47/ M | Pseudo | 3 | 16 | 1 | 13 | 1 | 13 | 20/30 | MM | Oxane removed, Permanent SO |
RRD | 64/ F | Phakic | 2 | 15 | 1 | 15 | 1 | 25 | CF 0.5 M | CF 1 M | SO emulsification, Oxane removed, Permanent SO |
RRD | 66/ M | Pseudo | 15 | 20 | 0 | 20 | 0 | 101 | 20/40 | LP | SO emulsification, IONN, Oxane removed, Permanent SO |
RRD | 66/ M | Pseudo | 9 | 14 | 0 | 12 | 0 | 8 | HM | CF 1 M | ERM |
RRD | 47/ M | Pseudo | 7 | 10 | 1 | 17 | 0 | 21 | 20/50 | 20/80 | |
TRD | 66/ M | Phakic | NA | 14 | 2 | 13 | 2 | 55 | LP | LP | Previous GDD for DR NVG, SO emulsification, Permanent Oxane |
TRD | 66/ M | Phakic | 34 | 20 | 2 | 14 | 2 | 63 | HM | 20/400 | Previous GDD for DR NVG, SO emulsification, Permanent SO, Ciclophotocoagulation, IONN, Corneal graft |